Cardia International A/SActive

CVR 35812563

Key figures

-654.742 kr.+66,6%
Gross profit 2025/26
-2 m-1,5 m-1 m-500 k02024/252025/26

Key ratios

2025/26
Balance sheet structure
Current assetsNon-current assetsLiabilities and provisionsEquity
05 m10 m2024/252025/26
Financial statements2025–2026
2024/252025/26
Balance sheet — assets
Cash and cash equivalents55.704367.465
Total current assets3.254.7533.087.000
Total non-current assets74.60074.600
Total assets3.329.3533.161.600
Balance sheet — liabilities and equity
Current liabilities8.453.5829.074.284
Non-current liabilities——
Total liabilities8.453.5829.074.284
Share capital746.000746.000
Retained earnings of previous periods-5.870.229-6.658.684
Profit for the year-2.381.620-788.455
Total equity-5.124.229-5.912.684
Income statement
Gross profit-1.958.213-654.742
Operating profit-2.324.297-654.742
EBITDA-1.958.213-654.742
Profit before income tax-2.381.620-788.455
Profit for the reporting year-2.381.620-788.455
Labour costs——
Depreciation of non-current assets366.0850
Other indicators
Employees00

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

About the company

Annual report 2026

Description of key activities of the companyCardia International A/S is manufacturing and selling the defibrillator CardiAid.

Significant changes in the company's activities and financial mattersThere have been no significant changes in activities and financial matters. The gross loss for the year totals EUR -88.000 thousand against EUR -262.000 thousand last year. Loss from ordinary activities after tax totals EUR -106.000 thousand against EUR -319.000 thousand last year. Management considers the net loss for the year as expected. The Company has incurred losses and has negative equity as of 31 March 2026. Furthermore, contrary to prior years, the parent company has not issued a support letter for the coming financial year. Management has prepared cash flow forecasts for the period ending 31 March 2027 and has assessed the Company’s expected liquidity requirements and available financing options. Based on the current forecast, anticipated operating performance and the ongoing dialogue with the Company’s stakeholders, management expects that the Company will be able to meet its obligations as they fall due. However, the absence of a support letter from the parent company represents a material uncertainty which may cast significant doubt on the Company’s ability to continue as a going concern. The annual report has nevertheless been prepared on a going concern basis, as management considers the assumptions applied in the liquidity forecast to be reasonable.

Excerpt from the management's review in the latest annual report.

Cardia International A/S — cvrprofil.dk